Cancer Research UK-funded scientists based at the University of Cambridge have identified a new target for the treatment of lung squamous cell carcinoma. Subscribe Advertise ...

Triple-negative breast cancer (TNBC) refers to any breast cancer that does not express the oestrogen receptor (ER), progesterone receptor (PR) and HER2 receptor; this disease subtype accounts for ...

The new drug target is the BCL11A gene, which researchers zeroed in on by studying 3,000 breast cancers and the genes that affect stem cells and developing tissue. Dr. Pentao Liu ...

Scientists pinpoint druggable target in aggressive breast cancer. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 10 / 221025153406.htm.

The first wave of targets has been classically druggable, where degradation-based therapies offer an alternative, and perhaps superior, mechanism of action to existing approved drugs. However, we are ...